DXPX and AACC Logos in white

Save an additional 10% with this coupon, powered by:

3 Days in Person + 2 Weeks of Digital Partnering
July 25th – 27th, 2023, Anaheim, CA – In the heart of the AACC Clinical Lab Expo

Elastrin Therapeutics is a South Carolina-based biotech developing novel therapies to reverse cardiovascular disease. Its underlying technology was developed by Dr. Naren Vyavahare during the last 20 years at Clemson University, in collaboration with Dr. Charles Rice.

Their team built a proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting.

matthias beurglemans
Matthias Breugelmans - CEO at Elastrin Therapeutics

Meet executives, investors & peers who share your passion.

Startups: Find your investor at DxPx for a successful future for your company.

DxPx Conference
chicago

As an industry partner, don’t waste time and make each meeting count.

Investors can expand their network and meet old & new acquaintances.

Get your tickets now!

Dont forget to use the code: 169-ELA-540 during the checkout process
DxPx US 2023